Skip to content
  • About Tekton Research
  • News
  • Contact
Tekton Research
Tekton Research
  • Join a Study
  • Sponsors & CROs
    • Capabilities
    • Therapeutic Areas
      • Neuroscience
      • Cardiometabolic
      • General Medicine
      • Infectious Disease
      • Pediatrics
    • Our Physicians
    • Leadership Team
    • Case Studies
    • Upcoming Events
  • Locations
    • Colorado
      • Boulder, CO
      • Denver, CO
      • Fort Collins, CO
      • Fort Collins, CO (Rheumatology)
      • Longmont, CO
    • Georgia
      • Suwanee, GA
    • Kansas
      • Wichita, KS
    • Missouri
      • Saint Louis, MO (Psychiatry)
    • New Jersey
      • Marlboro, NJ
    • Ohio
      • Cincinnati, OH
      • New Carlisle, OH
    • Oklahoma
      • Edmond, OK
      • Moore, OK
      • Tulsa, OK
      • Yukon, OK
      • Yukon, OK (Neurology)
      • Yukon, OK (Pediatrics)
    • Texas
      • Austin, TX
      • Austin, TX (Dermatology)
      • Beaumont, TX
      • Beaumont, TX (Pediatrics)
      • Coppell, TX
      • Irving, TX
      • McKinney, TX
      • San Antonio, TX
      • San Antonio, TX (Pediatrics)
    • Virginia
      • Midlothian, VA
      • Richmond, VA
  • Careers

Month: April 2025

Case Study: Achieving 172% of Enrollment Targets for a Global Phase 3 Trial

January 19, 2026April 25, 2025 by jlightner
Achieving 172% of Enrollment Targets for a Global Phase 3 Vaccine Trial

Tekton achieved an average of 172% enrollment across seven sites, enrolling more than 720 patients in a 2024 Global Phase 3 vaccine clinical trial.

Categories Advancing Medicine, Case Studies

Recent Posts

  • 2025 at Tekton Research: Building Momentum in High-Demand Therapeutic Areas
  • Tekton Research Adds Two New Sites to Expand Neuroscience and General Medicine Capabilities in Key U.S. Markets
  • Case Study: GLP-1 Medication Research Study
  • Understanding Lennox-Gastaut Syndrome (LGS)
  • Case Study: Phase 2 Migraine Research Study

Recent Comments

No comments to show.

Founded in 2006, Tekton Research is a multi-site clinical trial organization conducting Phase 1-4 trials in neuroscience, cardiometabolic, general medicine and infectious disease. Led by seasoned professionals and nationally recognized KOLs, Tekton delivers scientific rigor and operational excellence across trials of any size. The company partners with sponsors, CROs, and biopharma to accelerate the development of new therapies while maintaining a strong commitment to patient-centered care.

Tekton Research Logo - White Reversed
  • About Tekton Research
  • News
  • Contact
©2025 Tekton Research | All Rights Reserved | Privacy Policy
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}